Stratos Genomics raises $2.2 million for DNA sequencer

Stratos Genomics said today that it has raised an additional $2.1 million from existing shareholders. The money, which follows a $4 million round last summer, was provided by existing investors. “We are fortunate to have great results and supportive investors,” Stratos Genomics CEO Allan Stephan said in a statment. “Our shareholders recognize that we are… Read More


Accelerator Corp. hatches Oncofactor, a new Seattle cancer research startup

Accelerator Corp. has backed its 12th startup, a cancer research company that’s attempting to disrupt signaling pathways between tumors and the immune system. Dubbed Oncofactor, the company is just getting off the ground. But investors, including Carl Weissman of the biotech incubator Accelerator and Chad Waite of OVP, are bullish on the concept. “The Oncofactor technology platform… Read More


HIV drug maker Koronis considers IPO in London

We’ve bemoaned the fact that very few Seattle area companies are considering initial public offerings. But Koronis Pharmaceuticals, a Seattle company led by venture capitalist Donald Elmer, is positioning for an IPO in London either this year or next, Reuters reports. It would be a modest amount. Elmer tells Reuters that the company needs about… Read More